AHCO - CIK 0001725255
The table below shows AdaptHealth Corp.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $601.77M | $541.84M | $480.67M | $373.87M | $275.68M | $195.63M |
| Capital expenditure | $382.39M | $306.06M | $337.46M | $391.42M | $203.31M | $39.76M |
| Investing cash flow | -$303.19M | -$310.27M | -$357.28M | -$411.17M | -$1.82B | -$815.70M |
| Dividends paid | - | - | - | - | - |
AdaptHealth Corp. reported operating cash flow of $601.77M for fiscal year 2025. That is up 11.1% from $541.84M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from $68.43M (FY 2018) to $601.77M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $0.00 | $29.27M | $13.99M | $0.00 | $0.00 |
| Financing cash flow | -$302.19M | -$198.95M | -$92.53M | -$66.05M | $1.60B | $643.15M |